Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 1479 | 1417 | 0.0074 | 0.0082 | 0.9581 | 0.9545 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 1556 | 1484 | 0.0085 | 0.0082 | 0.9537 | 0.9545 |
A-375 | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 2592 | 213 | 0.1140 | 0.1060 | 0.0822 | 0.0803 |
WM-115 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 2349 | 217 | 0.5096 | 0.5180 | 0.0924 | 0.0997 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 1810 | 1651 | 0.0189 | 0.0193 | 0.9122 | 0.9069 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 1727 | 1557 | 0.0202 | 0.0193 | 0.9016 | 0.9069 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 3044 | 145 | 0.1389 | 0.1394 | 0.0476 | 0.0554 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 1712 | 1553 | 0.0189 | 0.0193 | 0.9071 | 0.9069 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 864 | 753 | 0.0132 | 0.0137 | 0.8715 | 0.8777 |
WM-115 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 2505 | 277 | 0.5325 | 0.5180 | 0.1106 | 0.0997 |
WM-115 | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1903 | 274 | 0.3894 | 0.3746 | 0.1440 | 0.1465 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 1025 | 897 | 0.0152 | 0.0137 | 0.8751 | 0.8777 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 933 | 827 | 0.0126 | 0.0137 | 0.8864 | 0.8777 |
WM-115 | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 2678 | 293 | 0.5701 | 0.5734 | 0.1094 | 0.1079 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 1293 | 1060 | 0.0277 | 0.0294 | 0.8198 | 0.8047 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 2 | 1294 | 999 | 0.0350 | 0.0294 | 0.7720 | 0.8047 |
WM-115 | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 2706 | 306 | 0.5737 | 0.5734 | 0.1131 | 0.1079 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 1205 | 991 | 0.0254 | 0.0294 | 0.8224 | 0.8047 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 1675 | 1292 | 0.0455 | 0.0451 | 0.7713 | 0.7585 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 3261 | 223 | 0.1456 | 0.1394 | 0.0684 | 0.0554 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 1493 | 1144 | 0.0414 | 0.0451 | 0.7662 | 0.7585 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 1557 | 1149 | 0.0484 | 0.0451 | 0.7380 | 0.7585 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 2938 | 147 | 0.1338 | 0.1394 | 0.0500 | 0.0554 |
WM-115 | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 2684 | 272 | 0.5765 | 0.5734 | 0.1013 | 0.1079 |
WM-115 | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1877 | 261 | 0.3863 | 0.3746 | 0.1391 | 0.1465 |